Biological systems are inherently complex and targeting a single molecule or pathway very rarely can have impact big enough in the diseases process that can be translated into therapeutic efficacy. There is a pressing need to develop an efficient process to test the combination of more than one therapeutic antibodies in the clinics. Our innovations will address this need.
Innovation
Scanning electron micrograph of T cells attacking a tumor cell.
Platform & Technologies
We’re building new technologies and platforms to produce the next generation of therapeutic antibodies that are capable of targeting multiple molecules and pathways.
